KEY ANNOUNCEMENTS AND PRESS RELEASES
INBRAIN NEWS & MEDIA
A collaboration has ensued between the Nanomedicine lab at the University of Manchester and two Barcelonian institutions. It was aimed at treating neurological disorders, and has successfully secured a £12M (€14.35M) investment...
INBRAIN Neuroelectronics develops intelligent graphene-based neural implants for personalized therapies in brain disorders...
Funding enables company to advance first-in-human studies for its flagship product, a less-invasive neuromodulation device for treating neurological conditions using artificial intelligence and graphene electrodes...
La start up con sede en Barcelona cierra una ronda de financiación de 14 millones liderada por Sabadell Asabys, Alta LS y el CDTI y prevé iniciar los ensayos clínicos este año...
Inbrain Neuroelectronics, a spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, has raised €14.3 million in a Series A funding round...
INBRAIN Neuroelectronics, a Graphene Flagship spin-off, has developed an intelligent graphene-based neural implant for personalised neurological therapy in brain disorders...
INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent graphene-brain interface, today announced $16.8 million in Series A funding for its disruptive system for treating...
Funding enables company to advance first-in-human studies for its flagship product, a less-invasive neuromodulation device for treating neurological conditions using artificial intelligence and graphene electrodes...
A collaboration between two Barcelona institutions and the Nanomedicine Lab at The University of Manchester - aimed at treating brain disorders such as epilepsy and Parkinson’s Disease - has secured £12m in funding, one of the largest investments to date in the European medical nanotechnology industry...
Inbrain Neuroelectronics, spin-off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, has raised €14.3 million in a Series A financing round led...
INBRAIN Neuroelectronics, a Graphene Flagship spin-off, has developed an intelligent graphene-based neural implant for personalised neurological therapy in brain disorders...
INBRAIN Neuroelectronics, a spin-off company of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, announces a €14.35M Series A investment...
INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, DeepTech and Digital Health...
INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, DeepTech and Digital Health...
INBRAIN Neuroelectronics is a spin-off company of Graphene Flagship partners the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, Spain. It was established in 2019, at the intersection between MedTech, DeepTech and Digital Health...
INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, DeepTech and Digital Health...
La compañía, surgida del Instituto Catalán de Nanociencia y Nanotecnología (ICN2) e Icrea, también ha contado con el respaldo económico del Cdti y dos inversores internacionales...
INBRAIN Neuroelectronics es una spin-off del Instituto Catalán de Nanociencia y Nanotecnología (ICN2) e ICREA, socios del Graphene Flagship, establecida en 2019 en la interesección entre las industrias Medtech, Deep Tech y Digital Health...
INBRAIN Neuroelectronics is a spin-off company from Graphene Flaship partners’ the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, established in 2019 in the intersection between Medtech, DeepTech and Digital Health...
In Europe, there are 165 million living with a brain disorder, and one in three people are predicted to suffer with some neurological disorder during their lifetime. Each year, the cost of treating brain disorders equates to 35% of Europe’s total disease burden — that’s almost €800 billion...
BStartup Health, el programa dedicado a startups de salud de Banco Sabadell, ha realizado la primera inversión entre las startups seleccionadas en la tercera convocatoria del programa. Se trata de Inbrain Neuroelectronics, spin-off del Instituto Catalán de Nanociencia y Nanotecnología (ICN2) e ICREA...
Banc Sabadell ha presentat avui els sis projectes de salut seleccionats durant 2019 i 2020 pel programa BStartup Health. Aquest programa, creat en 2018, va dirigit a projectes de salut en fases molt inicials (pre-seed i seed)...
BStartup Health, el programa dedicado a startups de salud de Banco Sabadell, ha invertido 100.000 euros en la empresa Inbrain Neuroelectronics, que desarrolla terapias de neuromodulación utilizando una interfaz neuronal revolucionaria basada en el grafeno...
The CEO of INBRAIN Neuroelectronics, Carolina Aguilar, talks about using graphene-based implants to treat patients with brain disorders...
Graphene Flagship spin-off INBRAIN Neuroelectronics has just received a €1 million investment from Sabadell Asabys, Alta Life Sciences, ICF and Finaves. This spin-off was born from Graphene Flagship partners the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA to speed up...
A spin-off from the Graphene Flagship is INBRAIN Neuroelectronic. The Spanish company is developing graphene-based implants to improve and personalise the treatment of brain disorders, including Parkinson’s and epilepsy...
Graphene-based biosensors could usher in an era of cancer liquid biopsies after a new study has shown that crumpled graphene is highly sensitive to DNA through its creation of electrical ‘hot spots’...
InBrain Neuroelectronics utiliza electrodos de grafeno del tamaño de una célula para modular la actividad de pequeños grupos de neuronas...
INBRAIN Neuroelectronics, a spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) at the Barcelona Institute of Science and Technology, recently announced a funding round from private and institutional investors...
A new bendable supercapacitor that can potentially transform portable power supply has been developed by a team of chemists, engineers, and physicists from UCL and the Chinese Academy of Science...
A Future and Emerging Technologies (FET) workshop on graphene and related materials (GRM) took place in Brussels on 20th January 2020. The goal of this workshop was to discuss the most important challenges of graphene and related materials in different areas of application...
Ambos expertos en electrónica han liderado el desarrollo de un implante de grafeno capaz de medir un tipo de actividad cerebral poco conocida porque era casi inaccesible. Su objetivo es...
This article showcases Startup Pill’s top picks for the best Medical Device startups. These startups are taking a variety of approaches to innovating inside of the medical device industry and around the world. They are all exceptional startups well worth a follow...
Graphene Flagship researchers develop a sensor that records brain activity at extremely low frequencies and could lead to new treatments for epilepsy...
Researchers in Barcelona have developed a graphene-based implant able to record electrical activity in the brain at extremely low frequencies and over large areas, unlocking...
INBRAIN Neuroelectronics, a spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2), a centre of the Barcelona Institute of Science and Technology (BIST), and ICREA, receives funding from...
For further information,
kindly contact Us at info@inbrain-neuroelectronics.com
Associate member of Graphene Flagship
Centre for the Development of Industrial Technology (CDTI)
European Comission
